Medscape: Analysis boosts Fluvoxamine for COVID, but what's the evidence?
UC expert says research may be useful, but more trials are needed
A report published recently in JAMA Open Network finds there's a strong likelihood that the antidepressant fluvoxamine (Luvox) may moderately lower rates of hospitalization due to COVID-19 in unvaccinated patients. However, outside experts cited by Medscape differ over whether the evidence from just three studies is strong enough to warrant adding the drug to the COVID-19 treatment arsenal. One of those experts sources is Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine.
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine/Photo/Joe Fuqua II/UC Creative + Brand
"This research might be valuable, but the jury remains out until several other adequately powered and designed trials are completed," said Fichtenbaum, who's familiar with the findings. "I'm not sure how useful this is given we have several antiviral agents available. Why would we choose this over Paxlovid, remdesivir, or molnupiravir?"
According to Fichtenbaum, researchers began focusing on fluvoxamine after case reports about patients improving while on the medication. This led to further interest, he said, boosted by the drug's known ability to dampen the immune system.
Lead photo/Science News
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
UC student leaders prioritize well-being, collaboration and spirit
April 28, 2026
Wilaini Alicea and Zohair Siddiqui were elected UC student body president and student body vice president in March. The two student leaders discuss their priorities for student government.
Emeriti professors make $1 million gift to UC’s College of Medicine
April 28, 2026
Henry A. Nasrallah’s life’s work has been focused on helping others. His vocation as a psychiatrist, researcher and educator is closely intertwined with his personal commitment to philanthropy, reflecting a deep dedication to improving psychiatric care, particularly by advancing research in neurobiology and treatments for schizophrenia and related disorders.
UC reinstalls Bearcat sculpture in time for commencement
April 27, 2026
The University of Cincinnati reinstalled the Fighting Bearcat statue after it was removed three years ago to make way for the new Sheakley Indoor Practice Facility and reconstruction of Champions Way.